Business Wire

Pulse Biosciences Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode System

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, today announced ...
WTVR.com

New heart procedure helps mountain biker overcome irregular heartbeat

Mountain biker Jerry Veggian overcame atrial fibrillation with pulse field ablation. AFib cases expected to grow from 5 ...
Nasdaq

Pulse Biosciences Announces First-in-Human Procedures with its Novel CellFX™ Nanosecond Pulsed Field Ablation (nsPFA™) Cardiac Catheter

Company’s proprietary system used to treat initial five patients in first-in-human feasibility study for patients with atrial fibrillation HAYWARD, Calif.--(BUSINESS WIRE)-- Pulse Biosciences, Inc.
Business Wire

Pulse Biosciences Announces Positive Clinical Data on Nano-Pulse Stimulation Procedure for Low-Risk Basal Cell Carcinoma Lesions

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, ...
Seeking Alpha

Pulse Biosciences: Interesting Product, But No Revenue Stream

Pulse Biosciences, led by billionaire Robert Duggan, focuses on nonthermal nsPFA technology for soft tissue ablation, particularly in cardiology and benign thyroid nodule treatments. Despite promising ...
Albuquerque Journal

'A huge change': New Mexico completes its first ever Farapulse procedure

Growing up in El Paso, Joe Udell used to spend much of his free time racing bikes. From the age of 14, he rode nearly every weekend in El Paso and neighboring Ciudad Juárez. This weekend passion would ...